Actoz Soft (052790) Stock Outlook 2026: Legend of Mir Royalties and the Chinese Control Puzzle
Start here before you touch Actoz Soft
My read is that the most useful thing you can do with Actoz Soft is set the word “game company” aside for a moment and look at it as what it really is: a licensing entity that runs on one 20-year-old piece of intellectual property. What actually drives the income statement is not a new hit, it’s the royalty from Legend of Mir — known in China as 热血传奇 — that still churns through Chinese servers today. Miss that structure and the stock’s price action makes no sense.
Here’s my conclusion up front. Actoz Soft sits on a powerful, durable IP cash flow, but the control over that cash flow is not fully in the company’s own hands, and you have to stare straight at that double structure. The royalties flow, but the rights around them are shared with Wemade, and control of the company itself is held by Chinese capital. An attractive cash flow and a complicated ownership-and-rights structure are fused into the same body.
Anyone who remembers Legend of Mir 2 knows this IP’s pull in their bones. Built jointly by Wemade and Actoz in 2001, the MMORPG hit far bigger in China than in Korea, and 热血传奇 became the first online game for a generation of Chinese players. Two decades later that nostalgia IP still gets recycled endlessly into web games, mobile titles, and mini-games, throwing off royalties the whole way. That kind of IP durability is rare even by gaming standards.
For a US investor this is an unusual name to categorize. It’s a Korean company on the KOSDAQ, but the controlling shareholder is Chinese, and its earnings are rooted in the Chinese market and Chinese IP policy. Investors who understand that dual nationality do far better than those who buy it as a cheap Korean game stock and stop there.
👉 It’s worth reading this against the NCsoft (036570) stock outlook 2026, whose pure self-developed model throws Actoz’s royalty structure into sharp relief.
The business model: royalties first, game development second
Break Actoz Soft into segments and you get roughly three pieces: Legend of Mir IP royalties, subsidiary game development and publishing, and new-IP or investment attempts. The problem is how badly the weight is skewed among them.
Legend of Mir royalties are the center of the P&L. The Legend of Mir 2 IP is co-owned by Actoz and Wemade. When a game built on it earns revenue in China, licensing fees are generated and a share goes to the joint copyright holders. China’s 热血传奇 ecosystem is enormous — not just officially licensed games but a vast field of derivative web games and mobile 传奇-genre titles. Actoz holds one axis of this IP and collects the royalty.
The subsidiary game business is a supporting act. Actoz holds a development studio subsidiary that owns the Dragon Nest IP and runs its own development and publishing. Dragon Nest is a recognizable action MMORPG IP across China and Asia, but it does not throw off anything close to Mir’s cash flow.
Put the real weight of the three in a table and the structure is obvious.
| Business axis | Nature | Cash-flow contribution | Degree of control |
|---|---|---|---|
| Legend of Mir IP royalties | Legacy IP licensing fees | Largest (the anchor) | Shared with Wemade + China policy |
| Dragon Nest and subsidiary games | Own development/publishing | Supporting | Relatively high |
| New IP / investment | Future growth attempts | Still minor | Company discretion |
The takeaway is stark. The area that earns the most cash (IP royalties) is the one the company controls least, and the area it controls most (own games) doesn’t yet earn much. That mismatch is the root of the frustration investors feel with Actoz.
How the Legend of Mir IP keeps earning after 20 years
Game IP usually has a short life. Even a title that defines an era typically sees revenue collapse within five to ten years. So why has Legend of Mir survived past 20? If you can’t answer that, half of the Actoz thesis is empty.
The key lies in China’s peculiar IP consumption structure. The generation that first played 热血传奇 is now in its 30s and 40s — players with spending power and strong nostalgia. Countless Chinese studios have targeted that nostalgia, building an entire genre called 传奇 games. Mir-based web games, mobile titles, and mini-games pour out constantly, and some of them take official licenses and pay royalties.
Here Actoz’s moat is not development skill — it’s the copyright itself. Holding one axis of the original Legend of Mir 2 copyright creates a potential royalty claim against everyone in China who wants to commercialize the IP. That’s the sort of asset that doesn’t wear down easily with time.
But the moat has two cracks. First, the rights are shared. Because it’s co-owned with Wemade rather than owned outright, conflicts arise over royalty allocation and licensing authority. Second, unauthorized use is rampant. China is full of private servers and derivative games that copy the Mir IP without a license. Holding a right and fully monetizing it are two different problems.
So the Mir IP is astonishingly long-lived, but that longevity is closer to “maintenance” than “growth.” It gives Actoz a stable royalty floor; building new growth on top of it is entirely up to the company.
Chinese control: the single most decisive key to Actoz
The biggest reason not to mistake Actoz for a plain Korean game stock is its control structure. In 2004 China’s Shanda took control of Actoz, and Chinese capital — running through Shengqu Games and the Century Huatong group — has been the effective controlling shareholder since. It’s a KOSDAQ listing, but the center of gravity for decisions sits in China.
Look coldly at what that implies.
First, minority-shareholder alignment. When the controlling shareholder is a foreign parent, there’s no guarantee that capital-allocation decisions — dividends, investment, related-party deals — line up with minority interests. Even when royalty cash piles up inside the company, how it gets returned to shareholders depends heavily on the controller’s judgment.
Second, conflict of interest in the IP disputes. If the party commercializing the Mir IP in China is connected to the controlling shareholder’s group, then the “payer” and the “payee” of the royalty end up mixed under one roof. That structural conflict is part of why Wemade spent years fighting Shanda and Actoz over unpaid royalties.
Third, direct exposure to China risk. Game-license (banhao) policy, minor-play regulation, and capital-flow controls all hit Actoz’s results directly. It’s a Korean listing whose earnings are rooted in China’s regulatory environment.
Stocks with this kind of control structure carry a “governance discount.” Even when the shares look cheap against assets or cash flow, you should accept that the discount exists for a reason.
👉 On the interplay of governance and release cycles, the Netmarble (251270) stock outlook 2026 and its affiliate-and-IP dependence make a useful comparison.
The Wemade IP litigation: how to weigh this risk
You can’t analyze Actoz without the Wemade relationship. The two are the original co-developers of Legend of Mir 2 and joint copyright holders. And that partnership has written a 20-year love-hate history swinging between cooperation and lawsuits.
The dispute centers on three things.
Royalty allocation: how to split the royalties generated by the Mir IP in China. Given the joint-copyright nature, the split ratio and settlement method have drawn repeated disagreement.
Licensing authority: who holds the right to license the Mir IP to third parties in China, and how far that right extends. Actoz (and controlling shareholder Shanda) and Wemade each issued licenses, and the scope of those rights collided.
Enforcement against unauthorized use: who acts, and how, against games that copy the Mir IP without a license. Wemade pushed hard against unlicensed Chinese games on the strength of its Mir copyright, winning favorable rulings through Singapore international arbitration among other venues.
From an investor’s seat this litigation risk is a double-edged sword. If Wemade enforces the IP aggressively and the royalty pie grows, Actoz as a joint copyright holder can theoretically benefit. If a ruling goes against the Actoz/Shanda side, the royalty claim wobbles. That’s exactly why a single litigation headline can move the stock so much. This is less a business risk than a risk over the size and ownership of legal rights.
The new-title drought: a royalty company’s most painful weakness
Legacy IP royalties are a fine floor, but they can’t be a growth story. Actoz’s most fundamental weakness is its repeated failure to produce new hits that could replace or surpass the Mir royalty.
Dig in a bit. The ideal growth path for a game company is a virtuous loop: (1) earn stable cash from existing IP, (2) reinvest that cash into new development, and (3) create the next big IP to keep growth going. NCsoft’s Lineage and Pearl Abyss’s Black Desert are examples. Actoz keeps getting stuck at the third link — creating the next major IP.
The causes are layered: a Chinese-affiliated controller that tilts development resources and priorities toward the Chinese market and recycling Chinese IP, a relatively shrunken in-house development organization, and the inertia bred by a giant IP that whispers “just keep milking what you have.”
The question an investor should ask coldly is this. Is Actoz a company that reinvests royalties to build the next leg of growth, or one that lets royalties drain out through dividends and related-party deals while slowly running down? If the answer looks more like the latter over time, no amount of stable cash flow will earn a re-rating.
👉 To see how a new-title pipeline and IP expansion lift a valuation, compare against the Pearl Abyss (263750) stock outlook 2026 and its Crimson Desert wait cycle.
Competitive positioning: what kind of game stock is this?
Line Actoz up next to other game stocks and its identity sharpens. Actoz is less “a company that grows on development skill” and more “a company that collects royalties on IP rights.”
| Company | Core revenue structure | Key IP | Control | Growth character |
|---|---|---|---|---|
| Actoz Soft (052790) | Legacy IP royalties + subsidiary games | Legend of Mir, Dragon Nest | Chinese-controlled | Maintenance (mature IP) |
| NCsoft (036570) | Direct sales of self-made MMORPGs | Lineage, Aion | Founder/owner-led | New-title-cycle dependent |
| Netmarble (251270) | Publishing + IP-partnership diversification | Seven Knights, partner IP | Owner/affiliate | New-title and M&A growth |
| Pearl Abyss (263750) | Own engine and IP, global service | Black Desert, Crimson Desert | Founder-led | Big-new-title bets |
Actoz’s spot in this table is clear. Where the others are “developers” whose shares swing on whether a new title lands, Actoz is a “rights holder” resting on a relatively predictable royalty floor, with its growth ceiling pressed down in exchange. The risk character is simply different: a smaller chance of crashing on a flop, and a smaller chance of spiking on a blockbuster.
For a US investor, it’s more accurate to classify Actoz within the game sector as a value/asset name rather than a growth name — cheap against its IP and cash-like assets — while accepting that the cheapness is a governance discount.
Actoz Soft investment risks: a reality check against the bull case
Prolonged new-title vacuum: as stressed, the most fundamental risk. Legacy IP alone doesn’t produce growth. Leave the pipeline empty and the market slowly re-rates this as an “aging cash flow.”
China policy risk: delayed or suspended banhao approvals, tighter minor-play rules, and shifts in policy toward foreign games can hit Mir’s Chinese commercialization directly. Roots in China are both the growth opportunity and the source of policy risk.
Litigation uncertainty: the outcome of Wemade royalty and licensing disputes changes the size and ownership of the royalty claim. A single ruling or award can shake the cash-flow premise.
Governance and minority-interest risk: with capital allocation centered on the Chinese controlling shareholder, minority interests can be pushed down the priority list. Keep watching related-party deals, loans, and dividend consistency.
Royalty-settlement volatility: IP royalties don’t arrive as smoothly as recurring product revenue. One-off settlements, retroactive true-ups, and FX swings make quarterly results lumpy. Don’t mistake one big royalty quarter for a trend.
FX and repatriation risk: bringing renminbi royalties earned in China back to Korea involves FX and capital-control variables. There can be a lag or gap between booked royalties and cash actually collected.
A US-investor angle: taxes and FX on a foreign KOSDAQ name
Actoz is a Korean KOSDAQ-listed stock, and most US investors would access it (where available) via a foreign brokerage or an over-the-counter proxy rather than a US-listed ADR. That changes the tax and FX math versus a domestic US name.
Holding period and brackets. For a US taxpayer, gains on a stock held longer than a year are taxed at long-term capital-gains rates (0%, 15%, or 20% depending on income), while under a year lands at ordinary-income rates. The 22% figure that Korean investors cite for foreign-stock gains is a Korean rule, not a US one — don’t import it. For a lumpy, event-driven name like Actoz, holding past the one-year line to reach the long-term rate can matter more than usual.
Foreign tax and dividends. Any dividend from a Korean company typically has Korean withholding applied at source; a US investor generally claims the foreign tax credit to avoid double taxation. Keep the paperwork, because reclaiming or crediting that withholding is where the real after-tax return is won or lost.
Won-dollar FX overlay. Actoz is priced in won, so your dollar return blends the stock’s move with the USD/KRW rate. A strengthening dollar erodes the dollar value of a won-priced gain; a weakening dollar amplifies it. Layer that on top of a company whose own earnings already run through renminbi-to-won conversion, and you’re carrying two FX exposures at once.
Position sizing. Given the governance discount, the China policy exposure, and the access friction, this is a small satellite position for most US portfolios, not a core holding. If you want steady income instead, a dividend vehicle is the cleaner tool.
👉 For building the income side of a portfolio, the SCHD dividend ETF guide 2026 sets a useful frame.
Metrics to watch each quarter
Tracking Actoz calls for a different scorecard than a typical game stock — royalty and governance items come before new-title metrics.
Priority 1: IP royalty revenue trend and mix. The share of revenue and profit coming from the Mir IP royalty, and its direction, matters most. A rising share means deepening dependence on legacy with no growth; a falling share can be a healthy sign that own-business is growing.
Priority 2: new-title pipeline progress. Track whether announced titles actually ship and whether the subsidiary development org produces output. An eternally empty pipeline erases the growth case.
Priority 3: China banhao and policy. Banhao approvals for new Mir-based games and shifts in Chinese game regulation drive the royalty outlook.
Priority 4: Wemade litigation and arbitration status. A direct input into the size and ownership of the royalty right — follow the schedule and direction of rulings.
Priority 5: related-party transactions with the controller. Intercompany loans, payout policy, and affiliate deals reveal how royalty cash aligns with minority interests. This is the real gauge of whether the governance discount narrows or widens.
Read those five together and you get past the “revenue up or down” headline to the actual health of Actoz as a royalty company.
👉 If you want a stock-selection frame that spans beyond gaming into broader growth themes, the AI stocks investment guide 2026 is worth a look.
Further reading
- 👉 NCsoft (036570) Stock Outlook 2026: The Lineage IP Moat and the New-Title Cycle
- 👉 Netmarble (251270) Stock Outlook 2026: The Publishing Model and IP-Partnership Strategy
- 👉 Pearl Abyss (263750) Stock Outlook 2026: The Crimson Desert Wait and the Valuation
- 👉 SCHD Dividend ETF Guide 2026: Building the Income Side of a Portfolio
This article is an investment opinion written for informational purposes and does not recommend buying or selling any specific security. Stock investing carries the risk of principal loss, and investment decisions should be made on your own judgment, taking your financial situation and risk tolerance into account. The business conditions and outlook for companies mentioned here reflect the time of writing; always verify the latest disclosures and professional opinions before investing.
What does Actoz Soft actually do?
Founded in 1996 and listed on Korea's KOSDAQ, Actoz Soft co-developed Legend of Mir 2 with Wemade in the early 2000s. That title became a national-scale hit in China under the name Woolim / 热血传奇, and its IP royalties remain the company's core cash flow. Through subsidiaries it also holds other IP such as Dragon Nest.
Is Actoz Soft really controlled by a Chinese company?
Yes. China's Shanda acquired control of Actoz back in 2004, and the ownership chain now runs through Shengqu Games and the Century Huatong group. It trades on Korea's KOSDAQ, but the controlling shareholder sits in China — and that dual identity is central to understanding the stock.
How do the Legend of Mir royalties get generated?
The Legend of Mir 2 IP is co-owned by Actoz and Wemade. When games built on that IP in China — the original 热血传奇 plus a sprawling web and mobile ecosystem — generate revenue, licensing fees flow, and a share goes to the joint copyright holders. That two-decade royalty stream is the anchor of Actoz's earnings.
What is the Wemade lawsuit about?
Wemade, Actoz, and China's Shanda have fought for years over Chinese licensing rights, royalty allocation, and unauthorized private servers and derivative games built on the Mir IP. Disputes reached international arbitration in Singapore. The tangled IP governance is a real risk factor for the stock.
What is Actoz Soft's biggest risk?
The absence of new hits. A large share of profit still comes from a 20-year-old legacy IP royalty, and the company has not consistently produced fresh commercial successes to replace or grow it. Layer on Chinese-controlled decision-making and minority-shareholder alignment concerns.
Does Actoz Soft pay a dividend?
The legacy IP cash flow gives it the capacity to pay, but the consistency and size of any dividend depend heavily on how the controlling shareholder allocates capital. Treat it as a royalty-and-governance story rather than a reliable dividend name.
Is the Legend of Mir IP still commercially relevant?
In China, 热血传奇 remains a powerful nostalgia IP for men now in their 30s and 40s, and it keeps getting recycled across web games, mobile, and mini-games. The IP's longevity is remarkable, but this is a mature IP being maintained, not one that is still growing.
How are Actoz Soft and Wemade related?
They are the original co-developers of Legend of Mir 2 and its joint copyright holders — partners and adversaries at once, cooperating on the IP's origin while fighting over royalties and licensing rights. Wemade's later expansion via Mir4 and MirM is entangled with Actoz's interests.
What moves Actoz Soft's share price?
Chinese IP royalty settlements, the outcome of Wemade litigation and arbitration, China's game-license (banhao) policy, and new-title news. One-off royalty settlements or a court/arbitration decision can swing the stock sharply.
What should investors watch each quarter with Actoz Soft?
The trend and mix of IP royalty revenue, new-title pipeline progress, Chinese banhao approvals, the status of Wemade-related litigation, and related-party transactions with the controlling shareholder (loans, dividends, intercompany deals). These reveal how durable — and how well-aligned — the royalty structure really is.
관련 글

Joycity (067000) Stock Outlook 2026: Long-Running Live IP Cash Cows Against the Gamble of New Releases

Gravity (GRVY / 117730) Stock Outlook 2026: The Ragnarok Single-IP Long Tail and New-Title Risk

Mgame (058630) Stock Outlook 2026: A Long-Life MMORPG Cash Cow With Small-Cap Whiplash

MS Autotech (123040) Stock Outlook 2026: Hot-Stamped Body Parts and the Tesla-Hyundai EV Lightweighting Trade

Hugel (145020) Stock Outlook 2026: Letybo's US Entry and the Botulinum Toxin Big 3 Challenge
